Delivery Order SPE2DB25D6040-SPE2DB25FTSWD

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DESCOVY 200-25 MG TABLET medical supplies. The $6,622.48 firm-fixed-price delivery order has a completion date of June 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order valued at $6,889.83 for the supply of DESCOVY 200-25 MG TABLET medication. The contract has an ultimate completion date of November 1, 2023 and is a firm fixed-price contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $10,434.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for DESCOVY 200-25 MG TABLET UU 30S, with a firm fixed-price pricing type and an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,726.11 firm fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of March 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,684.40 firm fixed-price delivery order covers the supply of DESCOVY 200-25 MG TABLET (4567631381) with a completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $18,190.23 awarded by the Defense Logistics Agency (DLA). The contract covers the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of November 26, 2024. The contract was awarded on November 25, 2024 and is a Firm Fixed Price arrangement. This Delivery Order appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,528.45 firm fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET medical products. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.08 firm fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp is a $19,533.88 Firm Fixed Price Delivery Order for DESCOVY 200-25 MG TABLET UU 30S medical supplies. The award was made by the Defense Logistics Agency (DLA) with a completion date of January 25, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,702.80 firm fixed-price delivery order contract is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB25D6040
    Indefinite Delivery Contract
  • SPE2DB25D6040-SPE2DB25FTSWD
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DESCOVY 200-25 MG TABLET. The contract, valued at $12,837.86, is a firm fixed price delivery order with a completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:54 AM